Article Author: Daniel M. Keller Publish date: October 6, 2016
PORTLAND, ORE. – A new device worn on one ear may help individuals with Parkinson’s to overcome speech deficits associated with the dis...
Article Author: Daniel M. Keller Publish date: October 6, 2016
BOSTON
Article Author: Daniel M. Keller Publish date: October 5, 2016
PORTLAND, ORE. – More than half of overweight, nondiabetic people with Parkinson’s disease were insulin resistant even though most had ...
Article Author: Daniel M. Keller Publish date: October 5, 2016
PORTLAND, ORE. – The presence of at least three out of four chemical biomarkers can predict the development of Parkinson’s diseas...
Article Author: Daniel M. Keller Publish date: October 5, 2016
PORTLAND, ORE.– Performing deep brain stimulation surgery for Parkinson’s disease using intraoperative CT imaging while the patient is ...
Article Author: Daniel M. Keller Publish date: October 5, 2016
For years, much of the information that has circulated about the relationship of diet to acne has been inconsistent. And while recent studies have ...
Article Author: Daniel M. Keller Publish date: October 4, 2016
PORTLAND, ORE. – Combining transcranial direct current stimulation and cognitive training resulted in an improvement in a greater number of c...
News Author: Daniel M. Keller Publish date: September 29, 2016
Key clinical point: Gait characteristics, not cognition, predict cognitive decline in early Parkinson’s.
Major finding: Gait pace, variabili...
News Author: Daniel M. Keller Publish date: September 27, 2016
News Author: Daniel M. Keller Publish date: August 25, 2016
News Author: Daniel M. Keller Publish date: August 9, 2016
Patients with acne rosacea, particularly the erythrotelangiectatic form, are considered good candidates for treatment with lasers and light therapies,...
News Author: Daniel M. Keller Publish date: July 30, 2016
News Author: Daniel M. Keller Publish date: July 29, 2016
Aluminum chloride preparations can effectively treat hyperhidrosis when used properly.
News Author: Daniel M. Keller Publish date: June 15, 2016
Combining an immunostimulator with pembrolizumab had good tolerability and safety, in a small phase Ib study.
News Author: Daniel M. Keller Publish date: June 15, 2016
Combining two immunotherapies, one inhibiting immune suppression and the other stimulating immune activation, is well tolerated and shows activity ...
